iTonic Holdings advances AI-powered cloud platform for nuclear medicine treatment planning

Product / Tech
โดย GlobeNewswire·Read original
Summary · why it matters

iTonic Holdings Ltd announced continued progress in developing its AI-enabled Treatment Planning System Cloud Platform through its 60%-owned subsidiary Mili Medical. The platform is being built to transform standalone treatment planning software into a browser-based, cloud collaboration tool integrating artificial intelligence, automated quality control, and healthcare data connectivity. Core cloud architecture, browser-based functionality, a medical data sharing framework, initial AI model training, and a quality control rule framework have been completed, with internal testing and clinical workflow validation now underway. The platform has not yet received regulatory approval or registration for commercial use, and the company is evaluating collaboration opportunities with healthcare institutions to support future deployment. iTonic Holdings aims to address digital transformation in precision medicine by enabling multi-location access, AI-assisted workflows for tasks like organ segmentation, and potential expansion into areas such as supply chain management and medical robotics integration.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
iTonic Holdings Ltd.
ITOC
▲ PositiveTechnologyrelevance

iTonic Holdings is advancing its AI-powered cloud platform for nuclear medicine treatment planning, a positive technology development.

Off-coverage companies 1

Mili (Jiangsu) Medical Technology Co., Ltd.Private▲ Positive
Technologyrelevance

Mili Medical, as the 60%-owned subsidiary, is the developer of the AI-enabled platform, directly benefiting from the progress.

© 2026 MarketDXNews